That’s a great idea Megashear, it’s pretty much just
That’s a great idea Megashear, it’s pretty much just been two of us trading posts every few days. Newcomers are welcome here to share ideas and opinions.
From what I can garner, operations are currently on hold due to lack of funds.
10Q is due this week, Tuesday I think, but may not show up til Friday or Monday if PT decides to use the 5 day extension.
In my opinion, PT is a long ways from done. Hoping for someone to step up and make this work.However , there are other avenues to explore, if PT can’t find a JV partner with deep enough pockets to advance his plans stated in the PR. Some of those avenues, we may not like, but they may be necessary.
There is always a willing predator who will offer toxic financing. It may be needed to hire a crew and equipment to get Elena up and running. If they truly believe they have solved the chemistry, it could be viable. I don’t know what shape the pad is in. Note term 12 months with no conversions before 6 months.
Another unfavorable but possible option is a reverse split. A 10 for 1 gives us roughly 80 million, or a 20 for 1 gives us 40 million outstanding. That makes it more marketable and attractive for conventional financing.
Again, not a great option, but better than seeing bankruptcy and a zero account balance. Bottom line line is company appears to be currently broke.
Anyone else have any other ideas to throw out?
Mexus Gold US (MXSG) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...
Continue Reading
Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...
Continue Reading
Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...
Continue Reading
Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....
Continue Reading
Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...
Continue Reading